Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...

As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...

The way in which we walk might hold the key to diagnosing Alzheimer's, or other types of dementia. Ground-breaking research ...

All 16 of Indiana’s designated senior care organizations — known as Area Agencies on Aging — are now required to have a ...

A simple digital health tool developed by Australian researchers could soon help predict the age of onset for early Alzheimer ...

Revised guidelines for amyloid and tau positron emission tomography for Alzheimer’s disease and dementia state these tests ...

A study has found cardiovascular conditions such as high blood pressure and diabetes, which are known to contribute to brain blood vessel damage in younger populations, not to be associated with an ...

China has launched a national plan to address the rapidly growing prevalence of dementia, which authorities say is becoming ...

A study from the Keck School of Medicine of USC has tested a biomarker linked to vascular dementia across four separate ...

Summary: A new study has identified a biomarker, DTI-ALPS, which connects glymphatic system dysfunction to vascular dementia.

China aims to have a sweeping action plan for dementia in place by 2030, encompassing all aspects of the disease, from ...

Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...